Company intelligence
Braingaze
Technology-driven early-stage detection and therapeutic support tools for ADHD, ASD, Alzheimer's Disease. CE Marked.
About Braingaze
Braingaze develops digital health solutions to detect, diagnose and treat cognitive disorders and diseases such as ADHD and Alzheimer's disease. Our solutions leverage brain circuits that connect small involuntary eye movements as a marker and enabler of cognitive processing. We call this eye movement cognitive vergence; whose use has been patented worldwide. Braingaze solutions have been used for years in leading clinics seeking better outcomes for their patients. Braingaze is powered by an international, interdisciplinary team of scientists (clinical, mathematicians and artificial intelligence experts), as well as product developers and entrepreneurs.
Verified activity
Signals from Braingaze
2 published signals
Research & Knowledge
Braingaze published a paper in GeroScience reporting on a 40Hz gamified eye-movement intervention associated with improvements in cognition and reductions in plasma pTau181 and pTau217 in individuals with early-stage MCI.
Reported by Hans Supèr
Research & Knowledge
Braingaze published a paper in GeroScience reporting on Oculomotor dynamics showing distinct condition-dependent patterns associated with AT(N) biological profiles in individuals with MCI.
Reported by Hans Supèr